Zoledronic acid and Dyspnea at rest - a phase IV clinical study of FDA data


Dyspnea at rest is reported only by a few people who take Zoledronic Acid.

The phase IV clinical study analyzes which people take Zoledronic acid and have Dyspnea at rest. It is created by eHealthMe based on reports of 22,448 people who have side effects while taking Zoledronic acid from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 22, 2022

22,448 people reported to have side effects when taking Zoledronic acid.
Among them, 4 people (0.02%) have Dyspnea at rest.

What is Zoledronic acid?

Zoledronic acid has active ingredients of zoledronic acid. eHealthMe is studying from 22,489 Zoledronic acid users for its effectiveness, alternative drugs and more.

What is Dyspnea at rest?

Dyspnea at rest is found to be associated with 519 drugs and 289 conditions by eHealthMe.

Number of Zoledronic acid and Dyspnea at rest reports submitted per year:

Could Zoledronic acid cause Dyspnea at rest?

Time on Zoledronic acid when people have Dyspnea at rest *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Dyspnea at rest when taking Zoledronic acid *:

  • female: 50 %
  • male: 50 %

Age of people who have Dyspnea at rest when taking Zoledronic acid *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Zoledronic acid *:

  1. Movicol: 2 people, 50.00%
  2. Avodart: 2 people, 50.00%
  3. Morphine Sulfate: 1 person, 25.00%
  4. Methylprednisolone Sodium Succinate: 1 person, 25.00%
  5. Letrozole: 1 person, 25.00%
  6. Herceptin: 1 person, 25.00%
  7. Combivent: 1 person, 25.00%

Common side effects people have besides Dyspnea at rest *:

  1. Stable Angina (a constant chest pain): 1 person, 25.00%
  2. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 1 person, 25.00%
  3. Disease Progression: 1 person, 25.00%
  4. Breathing Difficulty: 1 person, 25.00%

Common conditions people have *:

  1. Metastases To Bone (cancer spreads to bone): 3 people, 75.00%
  2. Prostate Cancer Metastatic: 2 people, 50.00%
  3. Enlarged Prostate: 2 people, 50.00%
  4. Constipation: 2 people, 50.00%
  5. Bone Pain: 2 people, 50.00%
  6. Vitamin B12 Deficiency: 1 person, 25.00%
  7. Pain: 1 person, 25.00%
  8. Lung Disorder (lung disease): 1 person, 25.00%
  9. High Blood Pressure: 1 person, 25.00%
  10. Breathing Difficulty: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Zoledronic acid and have Dyspnea at rest?

Check whether Dyspnea at rest is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Dyspnea at rest and when was it recovered:

Expand to all the drugs that have ingredients of zoledronic acid:

Alternative drugs to, pros and cons of Zoledronic acid:

Common Zoledronic acid side effects:

Browse all side effects of Zoledronic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Dyspnea at rest treatments and more:

COVID vaccines that are related to Dyspnea at rest:

Common drugs associated with Dyspnea at rest:

All the drugs that are associated with Dyspnea at rest:

Common conditions associated with Dyspnea at rest:

All the conditions that are associated with Dyspnea at rest:

How the study uses the data?

The study uses data from the FDA. It is based on zoledronic acid (the active ingredients of Zoledronic acid) and Zoledronic acid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: